Pembrolizumab versus paclitaxel for previously treated, advanced gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized clinical trials

This paper aims to compare the effectiveness and safety of pembrolizumab and paclitaxel as a second line for patients with locally advanced gastroesophageal cancer. METHODS: By searching PubMed, Scopus, Web of Science, and Ovid, any randomized clinical study comparing the effectiveness of paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Swed, Sarya, Shaheen, Nour, Hafez, Wael, Elsayed Talat, Nesreen, Rozan, Samah S., Diab, Rehab, Nashwan, Abdulqadir J., Motawea, Karam R., Alibrahim, Hidar, Albuni, Mhd Kutaiba, Battikh, Elias, Sawaf, Bisher, Shoib, Sheikh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726310/
https://www.ncbi.nlm.nih.gov/pubmed/36482610
http://dx.doi.org/10.1097/MD.0000000000031940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726310/
https://www.ncbi.nlm.nih.gov/pubmed/36482610
http://dx.doi.org/10.1097/MD.0000000000031940

Ejemplares similares